Osborne R, Perkins M A, Roberts D A
Human Safety Department, Miami Valley Laboratories, Procter & Gamble Company, Corporate Professional & Regulatory Services, Cincinnati, Ohio 45253-8707, USA.
Fundam Appl Toxicol. 1995 Nov;28(1):139-53. doi: 10.1006/faat.1995.1155.
A human cell-based in vitro method was developed to screen for ocular irritancy potential of aqueous compatible and incompatible test agents, such as liquids, insoluble solids, powders, granulars, emulsions, and acids/alkalis. Methods were developed for topical application (an exposure that mimics in vivo testing) and wash-off of test substances on the epithelial surface of human skin derived epithelial-fibroblast cocultures (Skin2 Model ZK1200 from Advanced Tissue Sciences). These cultures contain noncornified stratified squamous epithelium, providing a three-dimensional in vitro model that resembles noncornified mucosal epithelium, such as cornea and conjunctiva. The hypothesis tested and confirmed in this work was that the rate of cytotoxicity induced by topical application of test substances to the stratified epithelial cell cultures would correlate with ocular irritancy. Test substances were applied to the cell system for up to 30 min, and cytotoxicity was measured as decreased 3-[4,5-dimethylthiazol-2-yl]2,5-diphenyltetrazolium bromide (MTT) vital dye metabolism. The time (in minutes) of exposure to test agent that reduced MTT metabolism to 50% of control levels (the t50 value) was calculated for each test substance, and these values showed a good correlation (r = 0.87) with historic rabbit low-volume eye test maximum average scores (MAS) for a range of liquid, solid, granular, powder, and other test materials, including consumer product formulations and ingredient chemicals. Additionally, t50 values confirmed the mild nature of selected cosmetic formulations. Taken together, these data indicate that this in vitro test, termed the tissue equivalent assay, is a valuable tool to screen for irritancy of test substances to mucosal tissues, such as cornea and conjunctiva.
开发了一种基于人细胞的体外方法,用于筛选水性相容和不相容测试剂(如液体、不溶性固体、粉末、颗粒、乳液以及酸/碱)的眼刺激性潜力。开发了用于在源自人皮肤的上皮-成纤维细胞共培养物(Advanced Tissue Sciences公司的Skin2 Model ZK1200)的上皮表面局部应用(模拟体内测试的暴露)和冲洗测试物质的方法。这些培养物包含未角化的复层鳞状上皮,提供了一个类似于未角化黏膜上皮(如角膜和结膜)的三维体外模型。在这项工作中测试并得到证实的假设是,将测试物质局部应用于复层上皮细胞培养物所诱导的细胞毒性速率与眼刺激性相关。将测试物质应用于细胞系统长达30分钟,并将细胞毒性测定为3-[4,5-二甲基噻唑-2-基]-2,5-二苯基四氮唑溴盐(MTT)活性染料代谢的降低。针对每种测试物质计算将MTT代谢降低至对照水平50%(t50值)所需的暴露于测试剂的时间(以分钟计),并且这些值与一系列液体、固体、颗粒、粉末和其他测试材料(包括消费品配方和成分化学品)的历史兔低容量眼测试最大平均得分(MAS)显示出良好的相关性(r = 0.87)。此外,t50值证实了所选化妆品配方的温和性质。综上所述,这些数据表明这种体外测试(称为组织等效性测定)是筛选测试物质对黏膜组织(如角膜和结膜)刺激性的有价值工具。